CT-045 Primary Results From OUTREACH: A Phase II Study of Lisocabtagene Maraleucel (Liso-Cel) Administered in the Community Setting as Outpatient or Inpatient Treatment in Patients With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Year: 2023
Type: conference-abstract
Authors: Yuliya Linhares, Cesar Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris, Daanish Hoda, Juan C. Varela, Courtney Bellomo, Scott Cross, James Essell, Suzanne Fanning, Howard Terebelo, Habte Yimer, Jay Courtright, Jeff P. Sharman, Ana Kostic, Min Vedal, Ken Ogasawara, Ariel Avilion, Ricardo Espinola, Brenda Yuan, Bassam Mattar
Institutions: Baptist Hospital of Miami, Atlantic Health System, Colorado Blood Cancer Institute, Intermountain Healthcare, AdventHealth Orlando, New York Oncology Hematology, Virginia Oncology Associates, Oncology Hematology Care, Prisma Health, Newland Medical Associates, Willamette Valley Cancer Institute and Research Center, Bristol-Myers Squibb (United States), Cancer Center of Kansas
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4386282212